Macitentan for the treatment of inoperable chronic...

  • Main
  • 2017 / 9
  • Macitentan for the treatment of inoperable chronic...

Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Ghofrani, Hossein-Ardeschir, Simonneau, Gérald, D'Armini, Andrea M, Fedullo, Peter, Howard, Luke S, Jaïs, Xavier, Jenkins, David P, Jing, Zhi-Cheng, Madani, Michael M, Martin, Nicolas, Mayer, Eckhard,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet Respiratory Medicine
DOI:
10.1016/S2213-2600(17)30305-3
Date:
September, 2017
File:
PDF, 575 KB
english, 2017
Conversion to is in progress
Conversion to is failed